Pay in 4 interest-free payments of $6.56 Learn more
Ships within 48 hours Β· Estimated delivery Aug 16 - Aug 21
Funding This work was supported by the Henan Provincial Breast Cancer Precision Prevention and Control Engineering Research Center (ZC20220050), the Henan Provincial Peoples Hospital23456 Talent Engineering Project (ZC23456026) and the study on the Effect and Mechanism of Macrophage-Derived Exosomes Loaded with Doxorubicin for Targeted Therapy of Triple-Negative Breast Cancer (ZC20220114)
Always be in the know
Injecting unapproved peptides of uncertain purity for cosmetic scarring carries real risk for unproven benefit
Cost Implications of Dose Escalation Flat-Rate Model: Month 1-2 (2.5-5 mg): Pay: $349/month Medication cost: ~$100-160/month Other services: ~$150-200/month Provider margin: Low to moderate Month 6-12+ (12.5-15 mg): Pay: $349/month (same) Medication cost: ~$260-400/month Other services: ~$100-150/month Provider margin: Low to none Flat-rate means early months subsidize later monthsfair over full treatment course
Ultimately, results vary based on individual health needs, goals, and medical history
Legal action against Novo Nordisk may achieve justice and compensation for affected people
